跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44,920 条关于
“AIGH Capital Management LLC”
全部
44,920
临床试验
31,292
药物
644
机构
1,981
资讯
11,003
11个月前
Biofrontera Inc. Completes $11M Asset Acquisition of Ameluz and RhodoLED US Rights
去年
Biofrontera Acquires Full US Rights to Ameluz and RhodoLED, Secures $11M Funding
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
9个月前
Tang Capital Management Invests $56.8 Million in Celcuity Following Positive Phase 3 Gedatolisib Results
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
2个月前
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility to Strengthen Balance Sheet and Retire High-Cost Debt
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
第 1 页，共 1101 页
上一页
下一页
